Class summary at a glance.

Every drug in the Aldehyde Dehydrogenase Inhibitor class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $3.5Mcombined across class
Total Rx claims: 35K14K unique beneficiaries
Generic mfrs (active): 3across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Disulfiram

35K Part D claims (CY24) · 14K beneficiaries · First FDA approval: 2012-12-31

3 generic mfrs 0 plans require PA

Low NADAC$1.59

→

Avg plan cost$6.61

Part D spend $3.5M 4× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.